Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter January 26, 2021

Serendipitous detection of α1-antitrypsin deficiency: a single institution’s experience over a 32 month period

Thomas Cronin ORCID logo, Erum Rasheed, Aifric Naughton, Noel G. McElvaney, Tomás P. Carroll, Vivion E.F. Crowley and Niall Conlon

Corresponding author: Dr. Niall Conlon, Consultant Immunologist, Department of Immunology, St James’s Hospital, Dublin 8, Ireland; and Department of Immunology, Trinity College Dublin, Dublin, Ireland, E-mail:

  1. Research funding: None declared

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.


1. Aboussouan, LS, Stroller, JK. Detection of alpha-1 antitrypsin deficiency: a review. Respir Med 2009;103:335–41. in Google Scholar

2. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818–900. in Google Scholar

3. Laurell, CB, Eriksson, S. The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132–40. in Google Scholar

4. Donato, LJ, Jenkins, SM, Smith, C, Katzmann, JA, Snyder, MR. Reference and interpretive ranges for α 1-antitrypsin quantitation by phenotype in adult and pediatric populations. Am J Clin Pathol 2012;138 3:398–405. in Google Scholar

5. Franciosi, AN, Carroll, TP, McElvaney, NG. Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians. Lancet Respir Med 2019;7:1059. in Google Scholar

6. McKeeman, GC, Hall, SL, Freedman, DB. Reflex and reflective testing practice in Clinical Biochemistry in the United Kingdom – a national survey. Ann Clin Biochem 2020;57:77–87. in Google Scholar

7. Franciosi, AN, Hobbs, BD, McElvaney, OJ, Molloy, K, Hersh, C, Clarke, L, et al.. Clarifying the risk of lung disease in SZ alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2020;202:73. in Google Scholar

8. Molloy, K, Hersh, CP, Morris, VB, Carroll, TP, O’Connor, CA, Lasky-Su, JA, et al.. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes. Am J Respir Crit Care Med 2014;189:419–27. in Google Scholar

Received: 2020-11-24
Accepted: 2021-01-12
Published Online: 2021-01-26
Published in Print: 2021-06-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow